TRIM family proteins are involved in a broad range of biological processes, and their alteration results in many diverse pathological conditions found in genetic diseases, viral infections, and cancers. However, the spatial and temporal expression and function of TRIM9, one of TRIM family proteins, remain obscure. Our results here showed that TRIM9 protein is mainly expressed in the cerebral cortex, and functions as an E3 ubiquitin ligase collaborating with an E2 ubiquitin conjugating enzyme UbcH5b. Immunohistochemical examination revealed that TRIM9 is localized to the neurons in the normal mouse and human brain and that TRIM9 immunoreactivity is severely decreased in the affected brain areas in Parkinson's disease and dementia with Lewy bodies. This repressed level of TRIM9 protein was supported by immunoblotting analysis. Intriguingly, cortical and brainstem-type Lewy bodies were immunopositive for TRIM9. These results suggest that TRIM9 plays an important role in the regulation of neuronal functions and participates in pathological process of Lewy body disease through its ligase activity.
Introduction
Ubiquitination is a post-translational modification of protein substrates by ubiquitin, which is a highly conserved 76-amino acid polypeptide. Ubiquitination is essential for regulating the turnover of proteins for biological events such as inflammation, cell proliferation, and apoptosis (Hershko and Ciechanover, 1998; Kim et al., 2008; Zuccato et al., 2007) . This system is initiated by an ubiquitinactivating enzyme (E1), which activates and transfers ubiquitin to ubiquitin-conjugating enzymes (E2). Conjugation of target proteins with ubiquitin is then mediated by ubiquitin ligases (E3) (Hershko and Ciechanover, 1998) . In contrast to E1 and E2 enzymes, E3s are highly diverse, and there are two types: HECT and RING finger types. The latter has the RING finger motif characterized as the cysteine-and histidine-rich domain (Freemont, 2000) .
Tripartite motif (TRIM) proteins are composed of RING finger, Bbox, and coiled-coil domains, and have been defined as a subgroup of RING finger proteins based on their conserved structure (Reymond et al., 2001) . Recently, some members of TRIM proteins have been identified as an E3 enzyme, and play important roles in various cellular processes such as cell proliferation, tumorigenesis, and immune modification (Balint et al., 2004; Kong et al., 2007; Miyajima et al., 2009; Stremlau et al., 2004) . However, the function of most TRIM proteins has not yet been defined. TRIM9 belongs to TRIM family and its function remains unclear. In situ hybridization demonstrated that the expression of mouse TRIM9 mRNA is restricted to the central nervous system during the development from the embryo to the adult, but the distribution of TRIM9 protein in the nervous and non-nervous tissues remains unknown (Berti et al., 2002) . We speculated that TRIM9 protein is predominantly expressed in the brain, and is a brain-specific E3 ligase. To address this possibility, in vitro ubiquitination assays, and biochemical and immunohistochemical analyses were performed. The results in our studies showed that TRIM9 has an E3 ligase activity and is highly expressed in the cerebral cortex. Based on the spatial expression of TRIM9, we further hypothesized that alterations of TRIM9 protein occur in pathological conditions affecting the cerebral cortex. Indeed, TRIM9 immunoreactivity was severely decreased in the affected brain areas in Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Immunoblot analysis further revealed the reduction of TRIM9 expression in DLB brain. Intriguingly, cortical and brainstem-type Lewy bodies found in PD and DLB were immunopositive for TRIM9. This is the first demonstration of the role of TRIM9 involving the neurodegenerative disorders. Neurobiology of Disease 38 (2010) 210-218 
